Advancing cooperation on health technology assessment (HTA) and supporting the implementation of the new EU legal framework on HTA
Public consultation for D4.3.1, D5.2, D7.2 and D7.3 is now open until 30.08.2022.
EUnetHTA 21 announces that the public consultation for four deliverables D4.3.1 Practical guideline on comparators and comparisons, D5.2 Guidance on JCA Assessment Report Template, D7.2
EUnetHTA 21 announces publication of three deliverables
EUnetHTA 21 is pleased to announce the publication of three deliverables: D4.3.2 Methodological Guideline on direct and indirect comparisons; D4.7.1/2 Synthesis of national requirements /
Public consultation for D7.1 is now open until 19.08.2022
EUnetHTA 21 announces that the public consultation for the deliverable D7.1 – Guidance on interaction between Health Technology Developer and HTA is open until 19.08.2022,
Public consultation for D4.5; D4.6 and 5.1 is now open until 02.08.2022
EUnetHTA 21 announces that the public consultation for three deliverables D4.5 Applicability of Evidence; D4.6 Validity of clinical studies and D5.1 Guidance for JCA Submission
Deliverable D5.3.1 on selection criteria for JCA assessor and co-assessor is now published.
EUnetHTA 21 is pleased to announce the publication of the deliverable D5.3.1 on selection criteria for JCA assessor and co-assessor. More information can be found
Public Consultation for D4.7.3 and D4.7.4 is now open
EUnetHTA 21 announces that the public consultation for D4.7.3/D4.7.4 (EUDAMED data reporting template / Guidance for EUDAMED-based TISP process) is open until 05.07.2022, 23:59 CET.
Joint HTA Work
EUnetHTA develops several services that help inform the decision-making process around the introduction of pharmaceuticals and other technologies at the national, regional, and European levels. These include Joint Scientific Consultations, Parallel Consultations, and Post Launch Evidence Generation (PLEG). Find out more here.
Tools
EUnetHTA has developed a suite of tools to complement all steps in the collaborative joint work process, helping partners to proceed with a defined methodology. Access all current and archived tools here.
COVID-19 Response
EUnetHTA has prioritised COVID-19-related initiatives above other work during the current time. Here you will find updated information and publications relating to COVID-19 diagnostic testing, therapeutic treatments, and useful links to further data from our network partners.
Get Involved
EUnetHTA functions as a collaboration between network members and exterior partners to develop joint work. These include patients, industry, regulators, HCPs, and payers. Find out more about partner involvement, activities, and EUnetHTA events here.
